Literature DB >> 2166107

Regulation and development of cytochrome c-specific IL-4-producing T cells.

M Betz1, B S Fox.   

Abstract

The development of Ag-specific IL-4-producing T cells in short term cultures was examined. Freshly harvested lymph node cells from B10.A mice immunized with the cytochrome c fragment 81-104 did not produce detectable amounts of IL-4 upon Ag stimulation. However, after one cycle of bulk in vitro restimulation, the same cells could be stimulated to secrete IL-4. The development of Ag-specific IL-4-producing cells during the in vitro culture could be influenced by different culture conditions. When IL-4 and IL-1, in the presence of anti-IL-2R antibodies, were added to the bulk culture, secondary stimulation of the cells revealed increased levels of IL-4 production and constant or decreased levels of IL-2 production. The addition of IFN-gamma during the bulk culture led to a decrease in IL-4 production, yet had no effect on IL-2 production. When anti-IL-4 antibodies were present during the restimulation culture, no IL-4 was produced in the final stimulation assay. In addition, T cells cultured at high cell density produced more IL-4 in a secondary stimulation than did T cells cultured at low cell density. These results demonstrate that culture conditions during a short term culture of freshly harvested primed T cells may profoundly influence the development of IL-4-producing cells. This may be caused either by selective expansion or inhibition of preexisting IL-4-producing T cells, or by the differentiation of precursors of IL-4-producing cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.

Authors:  C Ekerfelt; C Dahle; R Weissert; M Kvarnström; T Olsson; J Ernerudh
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 2.  Induction of T helper cell subsets.

Authors:  M Röcken; K M Müller; C Hauser
Journal:  Springer Semin Immunopathol       Date:  1992

3.  IL-4 synthesis by in vivo-primed memory CD4+ T cells: II. Presence of IL-4 is not required for IL-4 synthesis in primed CD4+ T cells.

Authors:  R H DeKruyff; Y Fang; H Secrist; D T Umetsu
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 4.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

5.  Generation of rat Th2-like cells in vitro is interleukin-4-dependent and inhibited by interferon-gamma.

Authors:  A Noble; D Z Staynov; D M Kemeny
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

6.  Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells.

Authors:  A Noble; D M Kemeny
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

7.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.

Authors:  C S Hsieh; A B Heimberger; J S Gold; A O'Garra; K M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors:  R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4.

Authors:  L Spencer; L Shultz; T V Rajan
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Limiting dilution analysis reveals the precursors of interleukin-4-producing CD4+ cells induced by protein immunization.

Authors:  P L Groves; M H Pech; A B Troutt; A Kelso
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.